A Rostock

1.3k total citations
20 papers, 1.1k citations indexed

About

A Rostock is a scholar working on Cellular and Molecular Neuroscience, Organic Chemistry and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, A Rostock has authored 20 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cellular and Molecular Neuroscience, 5 papers in Organic Chemistry and 4 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in A Rostock's work include Neuroscience and Neuropharmacology Research (7 papers), Epilepsy research and treatment (4 papers) and Pharmacological Effects and Toxicity Studies (4 papers). A Rostock is often cited by papers focused on Neuroscience and Neuropharmacology Research (7 papers), Epilepsy research and treatment (4 papers) and Pharmacological Effects and Toxicity Studies (4 papers). A Rostock collaborates with scholars based in Germany, United States and Russia. A Rostock's co-authors include Chris Rundfeldt, Reni Bartsch, C. Tober, C. Herzog, Thomas J. Vogl, Falk Ochsendorf, Wolf‐­Henning Boehncke, Diamant Thaçi, Ralf J. Ludwig and Thomas M. Zollner and has published in prestigious journals such as Annals of the New York Academy of Sciences, Journal of Medicinal Chemistry and Biochemical Pharmacology.

In The Last Decade

A Rostock

19 papers receiving 997 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A Rostock Germany 10 475 421 269 231 147 20 1.1k
Laura Rauser United States 10 552 1.2× 433 1.0× 253 0.9× 82 0.4× 110 0.7× 11 1.4k
C. D. Nicholson United Kingdom 16 899 1.9× 267 0.6× 102 0.4× 79 0.3× 236 1.6× 35 1.3k
Jörge Beleta Spain 22 579 1.2× 176 0.4× 108 0.4× 70 0.3× 67 0.5× 50 1.3k
Ivan Milicic United States 19 554 1.2× 151 0.4× 144 0.5× 29 0.1× 164 1.1× 42 1.1k
Helen E. Benson United Kingdom 7 558 1.2× 265 0.6× 95 0.4× 31 0.1× 148 1.0× 8 1.2k
Michel Noyer Belgium 12 380 0.8× 568 1.3× 67 0.2× 468 2.0× 41 0.3× 22 961
Jo Mori Japan 17 346 0.7× 210 0.5× 95 0.4× 60 0.3× 79 0.5× 66 945
Carol S. Surowy United States 27 859 1.8× 328 0.8× 90 0.3× 48 0.2× 67 0.5× 51 1.6k
William A. Carroll United States 21 501 1.1× 251 0.6× 124 0.5× 119 0.5× 121 0.8× 44 1.5k
Ádám Vas Hungary 16 332 0.7× 200 0.5× 70 0.3× 70 0.3× 46 0.3× 23 917

Countries citing papers authored by A Rostock

Since Specialization
Citations

This map shows the geographic impact of A Rostock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Rostock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Rostock more than expected).

Fields of papers citing papers by A Rostock

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Rostock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Rostock. The network helps show where A Rostock may publish in the future.

Co-authorship network of co-authors of A Rostock

This figure shows the co-authorship network connecting the top 25 collaborators of A Rostock. A scholar is included among the top collaborators of A Rostock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Rostock. A Rostock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ludwig, Ralf J., C. Herzog, A Rostock, et al.. (2006). Psoriasis: a possible risk factor for development of coronary artery calcification. British Journal of Dermatology. 156(2). 271–276. 298 indexed citations
2.
Dost, Rita, A Rostock, & Chris Rundfeldt. (2004). The anti-hyperalgesic activity of retigabine is mediated by KCNQ potassium channel activation. Naunyn-Schmiedeberg s Archives of Pharmacology. 369(4). 382–390. 67 indexed citations
3.
Scheuer, K., et al.. (1999). Piracetam Improves Cognitive Performance by Restoring Neurochemical Deficits of the Aged Rat Brain. Pharmacopsychiatry. 32(S 1). 10–16. 54 indexed citations
4.
Lankau, Hans‐Joachim, et al.. (1999). 3-Amino- and 5-Aminopyrazoles with Anticonvulsant Activity. Archiv der Pharmazie. 332(6). 219–221. 8 indexed citations
5.
Lankau, Hans‐Joachim, et al.. (1999). Synthesis and anticonvulsant activity of new 4-aminopyrazoles and 5-aminopyrazol-3-ones.. PubMed. 54(9). 705–6. 3 indexed citations
6.
Rostock, A, C. Tober, Rita Dost, et al.. (1998). AWD-131-138. Drugs of the Future. 23(3). 253–253. 18 indexed citations
7.
Unverferth, Klaus, Jürgen Engel, A Rostock, et al.. (1998). Synthesis, Anticonvulsant Activity, and Structure−Activity Relationships of Sodium Channel Blocking 3-Aminopyrroles. Journal of Medicinal Chemistry. 41(1). 63–73. 142 indexed citations
8.
Rostock, A, et al.. (1998). AWD 131???138. Behavioural Pharmacology. 9(1). S79–S79. 3 indexed citations
9.
Rostock, A, C. Tober, Reni Bartsch, et al.. (1997). AWD 140–190: a new anticonvulsant with a very good margin of safety. Epilepsy Research. 28(1). 17–28. 9 indexed citations
10.
Müller, Wernér E.G., Sabrina Koch, K. Scheuer, A Rostock, & Reni Bartsch. (1997). Effects of piracetam on membrane fluidity in the aged mouse, rat, and human brain. Biochemical Pharmacology. 53(2). 135–140. 75 indexed citations
11.
Tober, C., A Rostock, Chris Rundfeldt, & Reni Bartsch. (1996). D-23129: a potent anticonvulsant in the amygdala kindling model of complex partial seizures. European Journal of Pharmacology. 303(3). 163–169. 130 indexed citations
12.
Rostock, A, C. Tober, Chris Rundfeldt, et al.. (1996). D-23129: a new anticonvulsant with a broad spectrum activity in animal models of epileptic seizures. Epilepsy Research. 23(3). 211–223. 213 indexed citations
13.
Воронина, Т. А., et al.. (1995). Synthesis and nootropic acitivity of N-acyl-4-phenyel-2-pyrrolidones. Pharmaceutical Chemistry Journal. 29(12). 844–847. 1 indexed citations
14.
Stoll, S., et al.. (1994). The Potent Free Radical Scavenger α‐Lipoic Acid Improves Cognition in Rodents. Annals of the New York Academy of Sciences. 717(1). 122–128. 26 indexed citations
15.
Ostrovskaya, R. U., et al.. (1993). Synthesis and neurotropic activity of a number of N-[di(n-propyl)acetyl]lactams. Pharmaceutical Chemistry Journal. 27(8). 546–550. 2 indexed citations
16.
17.
Fischer, H.-D., et al.. (1990). Effect of 2-Mercapto-Ethanol on Some Brain Biochemical Characteristics and Behavioural Changes in the Ageing CBA/Ca Mice. Pharmacology. 40(6). 343–348. 3 indexed citations
18.
Fischer, H.-D., et al.. (1990). Effect of 2-mercaptoethanol on posthypoxic and age-related biochemical and behavioural changes in mice and rats.. PubMed. 49(10). 1085–90. 4 indexed citations
19.
Rostock, A, et al.. (1989). Effects of carbamazepine, valproate calcium, clonazepam and piracetam on behavioral test methods for evaluation of memory-enhancing drugs.. PubMed. 11(9). 547–53. 11 indexed citations
20.
Ostrovskaya, R. U., et al.. (1983). [Antihypoxic effect of tisochromide (16-244) in comparison with piracetam].. PubMed. 38(4). 251–3. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026